The iconic rise of Viagra has consistently remained a benchmark of pharmaceutical success, however its legacy within the broader sector now presents questions about potential returns . Generic versions are diminishing exclusivity , leading to worries that betting on companies heavily reliant to Viagra's former position could be a dangerous strat… Read More